Data / Form D filings / Akava Therapeutics Inc.
Akava Therapeutics Inc.: Form D filings
Akava Therapeutics Inc., a pharmaceuticals company in Winnetka, IL, filed 4 Form D notices with the SEC between 2023 and 2026. The latest, on February 19, 2026, reports an offering of $15 million with nothing sold yet.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 755 SHERIDAN ROAD, Winnetka, IL, 60093
- Phone
- (847) 494-7434
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1966649
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | New notice | $15,000,000 | $0 | $15,000,000 | 0 | Yet to occur | sec.gov |
| Feb 21, 2025 | New notice | $500,000 | $100,000 | $400,000 | 1 | Feb 5, 2025 | sec.gov |
| Apr 23, 2024 | New notice | $5,000,000 | $0 | $5,000,000 | 0 | Yet to occur | sec.gov |
| Mar 3, 2023 | New notice | $10,000,000 | $0 | $10,000,000 | 0 | Yet to occur | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Richard Silverman | Executive Officer, Director | |
| Philip Silverman | Executive Officer, Director | |
| Brendan MacMillan | Director | |
| Joseph Nolan | Director | |
| Charles Polsky | Executive Officer, Director |
Every Form D from the week of Feb 16, 2026 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Akava Therapeutics Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.